In Vitro Study of Tumor Seeking Radiopharmaceutical Uptake by Human Breast Cancer Cell Line MCF-7 after Paclitaxel Treatment.
- Author:
Joon Young CHOI
1
;
Yong CHOI
;
Yearn Seong CHOE
;
Kyung Han LEE
;
Byung Tae KIM
Author Information
1. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. btnm.kim@samsung.com
- Publication Type:In Vitro ; Original Article
- Keywords:
F-18-fluorodeoxyglucose;
C-11-methionine;
Tl-201;
Tc-99m-MIBI;
Tc-99m-tetrofosmin;
paclitaxel;
MCF-7;
breast cancer;
cell viability
- MeSH:
Breast Neoplasms*;
Breast*;
Cell Count;
Cell Line*;
Cell Survival;
Dimethyl Sulfoxide;
Humans*;
MCF-7 Cells;
Paclitaxel*;
Radiopharmaceuticals
- From:Nuclear Medicine and Molecular Imaging
2007;41(5):364-372
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was designed to investigate the cellular uptake of various tumor imaging radiopharmaceuticals in human breast cancer cells before and after paclitaxel exposure considering viable cell number. MATERIALS AND METHODS: F-18-fluorodeoxyglucose, C-11-methionine, Tl-201, Tc-99m-MIBI, and Tc-99m-tetrofosmin were used to evaluate the cellular uptake in MCF-7 cells. MCF-7 cells were cultured in multi-well plates. Wells were divided into DMSO exposure control group, and paclitaxel exposure group. The exposure durations of paclitaxel with 10 nM or 100 nM were 2 h, 6 h, 12 h, 24 h, and 48 h. RESULTS: Viable cell fraction was reduced as the concentration and exposure time of paclitaxel increased. After 10 nM paclitaxel exposure, the cellular uptake of all 5 radiopharmaceuticals was not reduced significantly, irrespective of exposure time and viable cell fraction. After 100 nM paclitaxel exposure, the cellular uptake of all 5 radiopharmaceuticals was enhanced significantly irrespective of viable cell fraction. The peak uptake was observed in experimental groups with paclitaxel exposure for 6 to 48 h according the type of radiopharmaceutical. When the cellular uptake was adjusted for the viable cell fraction and cell count, the peak cellular uptake was observed in experimental groups with paclitaxel exposure for 48 h, irrespective of the type of radiopharmaceutical. CONCLUSION: The cellular uptake of F-18-fluorodeoxyglucose, C-11-methionine, Tl-201, Tc-99m-MIBI, and Tc-99m-tetrofosmin did not reflect viable cell number in MCF-7 cells after paclitaxel exposure for up to 48 h.
